SLU-PP-332 ORAL 500MCG: EXERCISE MIMIC, METABOLISM BOOST, ENDURANCE (2nd Image COA)

Description

Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. SLU-PP-332 is not approved for medical use, human consumption, or as a therapeutic treatment in this context.

Product Details

• Dosage: 500mcg per tablet

• Quantity: 50 tablets per bottle

• Form: Oral research tablets

• Packaging: Secure, sealed, tamper-proof container

• Source: High-quality lab-grade synthesis, third-party tested

• Purity: ≥98% verified by HPLC and mass spectrometry

Overview of SLU-PP-332’s Research Profile
SLU-PP-332 is a selective PPARδ (peroxisome proliferator-activated receptor delta) agonist being researched for its role in regulating lipid metabolism, mitochondrial energy output, and endurance-related biochemical pathways. By activating PPARδ, SLU-PP-332 has been studied for its ability to increase fatty acid oxidation, enhance mitochondrial biogenesis, and improve metabolic flexibility.

Its oral delivery format at 500mcg per tablet offers researchers the ability to standardize dosing protocols in long-term studies, enabling consistent data collection in metabolic, endurance, and mitochondrial efficiency experiments.

Research Specifics

• Lipid Metabolism Studies: Enhances fatty acid oxidation in laboratory models.

• Mitochondrial Function: Supports research into oxidative phosphorylation and cellular energy efficiency.

• Endurance Pathways: Studied for its influence on exercise-mimetic signaling and metabolic adaptation.

• PPARδ Activation: Allows examination of selective receptor binding and pathway specificity.

Key Features

• Form: Oral tablet for precise dosing

• Dosage: 500mcg per unit

• Quantity: 50 tablets per container

• Purity: ≥98% lab-verified via HPLC/MS

• Mechanism: Selective PPARδ receptor agonist

Potential Applications

• Modeling of fatty acid metabolism and lipid oxidation

• Comparative analysis of mitochondrial efficiency enhancers

• Research into exercise-mimetic signaling pathways

• Studies of metabolic flexibility in controlled test systems

Specifications
Each bottle of SLU-PP-332 oral tablets is packaged securely in tamper-proof containers to maintain stability and integrity. Tablets are formulated for consistent dosage delivery and require no reconstitution prior to use.